TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20569992

Group type: EXPERIMENTAL
Intervention: Standard definition of clinically significant change (PHQ-9 score ≤9 and 50% improvement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reliable and clinically significant change criterion c
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asymptomatic criterion
Number of subjects: 0
Study: 18427312

Group type: EXPERIMENTAL
Intervention: Full-endoscopic interlaminar and transforaminal technique
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conventional microsurgical technique
Number of subjects: 178
Study: 15949774

Group type: EXPERIMENTAL
Intervention: Conservative treatments for low back pain
Number of subjects: 269

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 269
Study: 11908905

Group type: EXPERIMENTAL
Intervention: CLA supplementation (1.5 g daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 9
Study: 10096389

Group type: EXPERIMENTAL
Intervention: DHEA treatment (50 mg orally once a day for 6 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment (one time a day for 6 months)
Number of subjects: 40
Study: 7756393

Group type: EXPERIMENTAL
Intervention: 20% LCT lipid emulsion with TPN
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 20% MCT‐LCT (50‐50) lipid emulsion with TPN
Number of subjects: 21
Study: 2187552

Group type: EXPERIMENTAL
Intervention: Tetradecyl sulphate
Number of subjects: 55

Group type: COMPARATOR
Intervention: Rolitetracycline
Number of subjects: 55
Study: 354521

Group type: EXPERIMENTAL
Intervention: Cefamandole nafate (CM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cephalothin sodium (CP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefamandole nafate (CM) and Cephalothin sodium (CP)
Number of subjects: 30
Study: 31992213

Group type: EXPERIMENTAL
Intervention: Flow-controlled ventilation (FCV)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 23
Study: 30782991

Group type: EXPERIMENTAL
Intervention: Sequential CQ-PQ treatment (arm 1)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Concomitant CQ-PQ treatment (arm 2)
Number of subjects: 204
Study: 28042020

Group type: EXPERIMENTAL
Intervention: Strength Training to Enhance Early Recovery (STEER)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual Care plus Attention Control with Health Education (UC + AC with HE)
Number of subjects: 67
Study: 24905134

Group type: EXPERIMENTAL
Intervention: N-butyl-2 cyanoacrylate (Histoacryl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: octyl cyanoacrylate (Dermabond)
Number of subjects: 0

Group type: COMPARATOR
Intervention: subcuticular suture
Number of subjects: 0
Study: 22908887

Group type: EXPERIMENTAL
Intervention: HAART interruption
Number of subjects: 14
Study: 21746799

Group type: EXPERIMENTAL
Intervention: HIV-positive women
Number of subjects: 4954

Group type: COMPARATOR
Intervention: HIV-negative women
Number of subjects: 4954
Study: 19921480

Group type: COMPARATOR
Intervention: Celecoxib plus placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pregabalin plus placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Celecoxib plus pregabalin
Number of subjects: 36
Study: 16236418

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond Primer/Bond (SE) with 20s photo-irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nano-Bond Primer/Photo-cure adhesive (PNB) with 10s photo-irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nano-Bond Primer/Photo-cure adhesive (PNB) with 20s photo-irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nano-Bond Primer/Dual-cure adhesive (DNB)
Number of subjects: 0
Study: 15061251

Group type: EXPERIMENTAL
Intervention: Intravenous porcine secretin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 11439794

Group type: COMPARATOR
Intervention: Morphine 1 mg/ml (group M)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Morphine 1 mg/ml plus ketamine 2 mg/ml (group K)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 9492501

Group type: EXPERIMENTAL
Intervention: Bolus injection of buprenorphine 0.1-0.2 mg with 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous infusion of buprenorphine 0.4 mg with 0.25% bupivacaine (40 ml at 1.7 ml.h-1)
Number of subjects: 60
Study: 7519114

Group type: EXPERIMENTAL
Intervention: Catheter removal on day 1 after surgery
Number of subjects: 59

Group type: COMPARATOR
Intervention: Catheter removal on day 2 after surgery
Number of subjects: 59
Study: 3128112

Group type: EXPERIMENTAL
Intervention: Cefotetan (1 gm IV before operation)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Cefoxitin (3 doses of 2 gm: first 30-60 min before operation, then 6 and 12 hours later)
Number of subjects: 355
Study: 31939347

Group type: EXPERIMENTAL
Intervention: Nurse-led food exchange intervention
Number of subjects: 142

Group type: COMPARATOR
Intervention: Routine dietary guidance and instruction (Control)
Number of subjects: 142
Study: 30690679

Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided intraarticular shoulder injection (IAI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 28727165

Group type: EXPERIMENTAL
Intervention: Diet (D)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Exercise (E)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Diet plus Exercise (DE)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 57
Study: 24482140

Group type: EXPERIMENTAL
Intervention: Social Network Analytic (SNA) measures of diffusion potential
Number of subjects: 5784

Group type: EXPERIMENTAL
Intervention: Global network index
Number of subjects: 5784

Group type: COMPARATOR
Intervention: Traditional analytic measures (e.g., participation rate, representativeness)
Number of subjects: 5784
Study: 23497392

Group type: EXPERIMENTAL
Intervention: Community health workers intervention
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 194
Study: 21714686

Group type: EXPERIMENTAL
Intervention: Genistein (30 mg daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 19095666

Group type: EXPERIMENTAL
Intervention: Increased access to emergency contraception (EC)
Number of subjects: 1490

Group type: COMPARATOR
Intervention: Standard access to emergency contraception (EC)
Number of subjects: 1490
Study: 16861075

Group type: EXPERIMENTAL
Intervention: Resin composites with fiber posts
Number of subjects: 90

Group type: COMPARATOR
Intervention: Resin composites without fiber posts
Number of subjects: 90
Study: 12719053

Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fiberoptic intubation
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study: 10788919

Group type: EXPERIMENTAL
Intervention: Pulsating low-air-loss surface
Number of subjects: 54

Group type: COMPARATOR
Intervention: Nonpulsating low-air-loss surface
Number of subjects: 54
Study: 9048269

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone 0.64 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone 1.25 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone 0.32 mg/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8322564

Group type: EXPERIMENTAL
Intervention: Caudal buprenorphine (4 micrograms.kg‐1 body weight)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intramuscular buprenorphine (4 micrograms.kg‐1 body weight)
Number of subjects: 44
Study: 3524648

Group type: EXPERIMENTAL
Intervention: Zaprinast (M&B 22,948, a single oral dose)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31997490

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy
Number of subjects: 834

Group type: COMPARATOR
Intervention: Control (single antiplatelet therapy)
Number of subjects: 834
Study: 29502273

Group type: EXPERIMENTAL
Intervention: High-dose flavanol
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-dose flavanol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 48
Study: 28622215

Group type: COMPARATOR
Intervention: Female-only teams
Number of subjects: 216

Group type: COMPARATOR
Intervention: Mixed teams (individual level)
Number of subjects: 216
Study: 25569324

Group type: COMPARATOR
Intervention: Dietary Guidelines (DG) group (n=61)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Dietary Guidelines + Physical Activity (DG+PA) group (n=60)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both groups pooled
Number of subjects: 121
Study: 23957512

Group type: EXPERIMENTAL
Intervention: Multiple imputation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Last observation carried forward
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed effects model or generalized estimating equations
Number of subjects: 0
Study: 21439306

Group type: EXPERIMENTAL
Intervention: Breakfast consumption
Number of subjects: 96
Study: 18067560

Group type: EXPERIMENTAL
Intervention: Anaesthetic nurse-controlled sedation (ACS) with propofol
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation (PCS) with propofol
Number of subjects: 153

Group type: COMPARATOR
Intervention: No intra-operative sedation (control)
Number of subjects: 153
Study: 17150053

Group type: EXPERIMENTAL
Intervention: Low tidal volume mechanical ventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: High positive end expiratory pressure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prone positioning
Number of subjects: 0
Study: 12835884

Group type: EXPERIMENTAL
Intervention: Disodium pamidronate (DP) 90 to 180 mg (stepwise increase) plus radiotherapy (30 Gy in ten fractions)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Disodium pamidronate (DP) 180 mg (flat dose) plus radiotherapy (30 Gy in ten fractions)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Radiotherapy only (group C)
Number of subjects: 42
Study: 10680442

Group type: EXPERIMENTAL
Intervention: Flutrimazole 1% cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketoconazole 2% cream
Number of subjects: 60
Study: 8693545

Group type: EXPERIMENTAL
Intervention: BT563
Number of subjects: 60

Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 60
Study: 1726411

Group type: COMPARATOR
Intervention: Selenium supplementation in the form of Se-salt (15 ppm anhydrous sodium selenite) for 5 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selenium supplementation in the form of Se-yeast (200 micrograms daily) for 4 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selenium supplementation in the form of Se-yeast (200 micrograms daily) for 2 years
Number of subjects: 0
Study: 7254893

Group type: EXPERIMENTAL
Intervention: Specific therapy
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Surgical operations
Number of subjects: 507

Group type: COMPARATOR
Intervention: Randomised therapeutic trial
Number of subjects: 507
Study: 30700174

Group type: EXPERIMENTAL
Intervention: Low serum pepsinogen I (PGI) indicating atrophic gastritis
Number of subjects: 2132

Group type: COMPARATOR
Intervention: Normal serum pepsinogen I (PGI)
Number of subjects: 2132

Group type: EXPERIMENTAL
Intervention: History of gastric surgery due to benign cause
Number of subjects: 2132

Group type: EXPERIMENTAL
Intervention: Gastroscopy
Number of subjects: 2132
Study: 27616192

Group type: EXPERIMENTAL
Intervention: Shaving (group A)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Snipping (group B)
Number of subjects: 129
Study: 27133551

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 207

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 207
Study: 24439655

Group type: EXPERIMENTAL
Intervention: Probiotics treatment
Number of subjects: 796

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 796
Study: 22240593

Group type: EXPERIMENTAL
Intervention: Carvedilol CR (10-80 mg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Carvedilol CR (80 mg/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Carvedilol IR (5-20 mg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Carvedilol CR
Number of subjects: 41

Group type: COMPARATOR
Intervention: Carvedilol IR
Number of subjects: 41
Study: 19651939

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with a volar plate
Number of subjects: 45

Group type: COMPARATOR
Intervention: Closed reduction and pin fixation
Number of subjects: 45
Study: 17544156

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg IV dexamethasone (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (control group, n=50)
Number of subjects: 100
Study: 11077907

Group type: EXPERIMENTAL
Intervention: Community Mothers Programme (intervention)
Number of subjects: 76
Study: 9411208

Group type: EXPERIMENTAL
Intervention: Middle latency auditory evoked potentials (MLAEP) recordings
Number of subjects: 65

Group type: COMPARATOR
Intervention: Brainstem auditory evoked potentials (BAEP)
Number of subjects: 65
Study: 8477913

Group type: EXPERIMENTAL
Intervention: 80 mg quinine HCl
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 120 mg quinine HCl
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 160 mg quinine HCl
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 32
Study: 3818024

Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31047351

Group type: EXPERIMENTAL
Intervention: Yellow laser (577 nm)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Green laser (532 nm)
Number of subjects: 40
Study: 27462023

Group type: EXPERIMENTAL
Intervention: Methylene blue staining
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (non-staining)
Number of subjects: 266
Study: 24633484

Group type: EXPERIMENTAL
Intervention: Homemade tracheotomy incision nursing pads
Number of subjects: 83

Group type: COMPARATOR
Intervention: Traditional tracheotomy nursing pads
Number of subjects: 83
Study: 23733756

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) 3,000 mg per day
Number of subjects: 409

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study: 19460872

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 20
Study: 18512996

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0
Study: 16189692

Group type: EXPERIMENTAL
Intervention: Synthetic transobturator (TOT) SAFYRE sling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autologous pubovaginal sling
Number of subjects: 20
Study: 12828985

Group type: EXPERIMENTAL
Intervention: 0.05M lactic acid gel (6% w/v hydroxyethyl cellulose, pH 4.5) with fluoride for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.05M lactic acid gel (6% w/v hydroxyethyl cellulose, pH 4.5) without fluoride for 7 days
Number of subjects: 40
Study: 10904044

Group type: EXPERIMENTAL
Intervention: Respiratory muscle unloading
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Respiratory muscle loading
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (unchanged respiratory muscle work)
Number of subjects: 7
Study: 8880847

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg plus 50, 100 or 200 mg of caffeine
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 1719654

Group type: EXPERIMENTAL
Intervention: Iloprost (maximum tolerated dose up to 2 ng/kg/min, administered as a six-hourly intravenous infusion for two to four weeks)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 728

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 728
Study: 30071046

Group type: EXPERIMENTAL
Intervention: Ridinilazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study: 26773515

Group type: EXPERIMENTAL
Intervention: Ketogenic medium chain triglyceride diet (MCTD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standardized placebo diet
Number of subjects: 21
Study: 23703980

Group type: EXPERIMENTAL
Intervention: Self-care support intervention (SCSI) utilizing a motivational interview
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 22111944

Group type: EXPERIMENTAL
Intervention: Portable force plate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Belt mat
Number of subjects: 40

Group type: COMPARATOR
Intervention: Contact mat
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vertec
Number of subjects: 40
Study: 20163806

Group type: EXPERIMENTAL
Intervention: Korean-speaking children (4-5 years)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Korean-speaking adults
Number of subjects: 2
Study: 18167176

Group type: EXPERIMENTAL
Intervention: Olopatadine hydrochloride 0.2%
Number of subjects: 52

Group type: COMPARATOR
Intervention: Tear saline (control)
Number of subjects: 52
Study: 16014139

Group type: EXPERIMENTAL
Intervention: High-normal blood pressure (DBP)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Hypertension (HTN)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: High-normal blood pressure (SBP)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: High-normal or high DBP or SBP
Number of subjects: 603
Study: 12839217

Group type: EXPERIMENTAL
Intervention: Sigg's technique using Aethoxysclerol
Number of subjects: 1622

Group type: EXPERIMENTAL
Intervention: Fegan's technique with Fibrovein
Number of subjects: 1622

Group type: EXPERIMENTAL
Intervention: Fegan's technique using a combination of Aethoxysclerol and Fibrovein
Number of subjects: 1622

Group type: COMPARATOR
Intervention: Fegan's technique
Number of subjects: 1622
Study: 11020756

Group type: EXPERIMENTAL
Intervention: Awake group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Anesthetized group (n = 20)
Number of subjects: 40
Study: 8669574

Group type: EXPERIMENTAL
Intervention: Ear, nose and throat training group (performed ten nasendoscopies on awake patients)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional training group (performed ten nasendoscopies on anaesthetised oral surgery inpatients)
Number of subjects: 12
Study: 1997235

Group type: EXPERIMENTAL
Intervention: Continuous passive-motion device with a mean interval of 75 hours a week and 12,000 cycles
Number of subjects: 51

Group type: COMPARATOR
Intervention: Traditional early passive-motion protocol with a mean interval of 4 hours a week and 1,000 cycles
Number of subjects: 51
Study: 6364334

Group type: EXPERIMENTAL
Intervention: Metronidazole 2000 mg in a single dose
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Metronidazole 400 mg three times daily for 5 days
Number of subjects: 25
Study: 31854293

Group type: EXPERIMENTAL
Intervention: Intensive treatment (42% of patients)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Guideline-recommended therapy (58% of patients)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: 140 - 150 mmHg systolic blood pressure group
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure ranging between 120 and 130 mmHg
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: High mean systolic blood pressure after blood pressure-lowering therapy
Number of subjects: 1500
Study: 30420315

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) with Stride Management Assist (SMA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional gait training
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT) with SMA
Number of subjects: 41
Study: 29560078

Group type: EXPERIMENTAL
Intervention: Audiovisual feedback (AVF) during chest compressions
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard chest compressions without audiovisual feedback
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Continuous chest compressions with audiovisual feedback
Number of subjects: 98
Study: 26825083

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture at Zusanli and Guanyuan
Number of subjects: 60
Study: 24807329

Group type: EXPERIMENTAL
Intervention: Topical aqueous 4% lidocaine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 49
Study: 21988083

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention (daily nurse-led, individual-based activities)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 20329606

Group type: EXPERIMENTAL
Intervention: Qingshen Granule (QSG), 1 bag thrice a day by oral intake for 1 month
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (conventional Western medical therapy + retention enema of Jiedu Xiezhuo No. II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Qingshen Granule (QSG) + retention enema of Jiedu Xiezhuo No. II
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal control group (20 healthy persons)
Number of subjects: 60
Study: 17563191

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 243
Study: 16275213

Group type: EXPERIMENTAL
Intervention: Therapy responders
Number of subjects: 79

Group type: COMPARATOR
Intervention: OCD patients
Number of subjects: 79
Study: 12095880

Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 409

Group type: COMPARATOR
Intervention: Tretinoin cream 0.05%
Number of subjects: 409
Study: 10463682

Group type: EXPERIMENTAL
Intervention: Thimerosal-preserved vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autoclaved vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lyophilized vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (fresh products)
Number of subjects: 0
Study: 7607607

Group type: EXPERIMENTAL
Intervention: Fructose infusion (15 min iv infusion at 0.185 mmol/kg BW/min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Glucose infusion
Number of subjects: 7